| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Influenza A M1 vaccine (Pascal Biosciences) | Phase 1 Clinical | Pascal Biosciences | Influenza A virus infections | 詳細 | |
| adenovector based vaccine (Pascal Biosciences/University of British Columbia) | Phase 1 Clinical | Nevis Brands Inc | Influenza A virus infections | 詳細 | |
| 90Y-2IT-BAD-Lym-1 | 90Y-2IT-BAD-Lym-1 | Phase 1 Clinical | National Cancer Institute | Lymphoma, Non-Hodgkin | 詳細 |
| Bezetabart debotansine | STRO-001; SP7675; SP-7675; BN-301 | Phase 1 Clinical | Sutro Biopharma Inc | Hematologic Neoplasms; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma | 詳細 |
| TROP-2-targeted anti-CD74 siRNA (Immunomedics) | Immunomedics Inc | Solid tumours | 詳細 |